Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia

Urologia Internationalis

Volumn 80, Issue 2, 2008, Pages 177-180

  Memis, Ali ^a   Ozden, Cuneyt ^a,b   Ozdal, Ozdem Levent ^a   Guzel, Ozer ^a   Han, Ozge ^a   Seckin, Selda ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Benign prostatic hyperplasia; Finasteride; Hematuria; Microvessel density

Indexed keywords

FINASTERIDE;

AGED; ANAMNESIS; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DRUG EFFECT; ECHOGRAPHY; HEMATURIA; HISTOPATHOLOGY; HUMAN; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE; PROSTATE HYPERTROPHY; PROSTATE SURGERY; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; TREATMENT DURATION;

AGED; ENZYME INHIBITORS; FINASTERIDE; HEMATURIA; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC HYPERPLASIA;

EID: 41149140223     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112610     Document Type: Article

References (17)

1. Kashif KM, Foley SJ, Basketter V, Holmes SA: Haematuria associated with BPH - natural history and a new treatment option. Prostate Cancer Prostatic Dis 1998;1:154-156.
2. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC: Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243-247.
3. Puchner PJ, Miller MI: The effects of finasteride on hematuria associated with benign prostatic hyperplasia: a preliminary report. J Urol 1995;154:1779-1782.
4. Miller MI, Puchner PJ: Effects of finasteride on hematuria associated with benign prostatic hyperplasia: long-term follow-up. Urology 1998;51:237-240.
5. Sieber PR, Rommel FM, Huffnagle HW, Breslin JA, Agusta VE, Harpster LE: The treatment of gross hematuria secondary to prostatic bleeding with finasteride. J Urol 1998;159:1232-1233.
6. Foley SJ, Bailey DM: Microvessel density in prostatic hyperplasia. BJU Int 2000;85:70-73.
7. Lynch TH, Waymont B, Dunn JA, Hughes MA, Wallace DM: Rapid diagnostic service for patients with haematuria. Br J Urol 1994;73:147-151.
8. Marshall S, Narayan P: Treatment of prostatic bleeding:suppression of angiogenesis by androgen deprivation. J Urol 1993;149:1553-1554.
9. Foley SJ, Soloman LZ, Wedderburn AW, Kashif KM, Summerton D, Basketter V, Holmes SA: A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride. J Urol 2000;163:496-498.
10. Saez C, Gonzalez-Baena AC, Japon MA, Giraldez J, Segura DI, Rodriguez-Vallejo JM, Gonzalez-Esteban J, Miranda G, Torrubia F: Expression of basic fibroblast growth factor and its receptors FGFR1 and FGFR2 in human benign prostatic hyperplasia treated with finasteride. Prostate 1999;40:83-88.
11. Monti S, Sciarra F, Adamo MV, Toscano V, Trotta MC, Martini C, Lanzara S, Silverio FD: Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide. J Androl 1997;18:488-494.
12. Haggstrom S, Torring N, Moller K, Jensen E, Lund L, Nielsen JE, Bergh A, Damber JE: Effects of finasteride on vascular endothelial growth factor. Scand J Urol Nephrol 2002;36:182-187.
13. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, et al: The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med 1992;327:1185-1191.
14. Lekas E, Bergh A, Damber JE: Effects of finasteride and bicalutamide on prostatic blood flow in the rat. BJU Int 2000;85:962-965.
15. Hochberg DA, Basillote JB, Armenakas NA, Vasovic L, Shevchuk M, Pareek G, Fracchia JA: Decreased suburethral prostatic microvessel density in finasteride-treated prostates: a possible mechanism for reduced bleeding in benign prostatic hyperplasia. J Urol 2002;167:1731-1733.
16. Pareek G, Shevchuk M, Armenakas NA, Vasjovic L, Hochberg DA, Basillote JB, Fracchia JA: The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients. J Urol 2003;169:20-23.
17. Donohue JF, Hayne D, Karnik U, Thomas DR, Foster MC: Randomized, placebo-controlled trial showing that finasteride reduces prostatic vascularity rapidly within 2 weeks. BJU Int 2005;96:1319-1322.